Puma Biotechnology Aktie
4,46
EUR
+0,02
EUR
+0,41
%
5,13
USD
-0,10
USD
-1,82
%
Werbung
Puma Biotechnology Aktie Analyse
10.05.19 | Puma Biotechnology Neutral | Cantor Fitzgerald | |
01.10.18 | Puma Biotechnology Overweight | Cantor Fitzgerald | |
11.05.18 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
10.11.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
02.10.17 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
06.06.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
25.05.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
02.03.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
Werbung
|
|||
21.09.16 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
29.03.16 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
23.01.15 | Puma Biotechnology Outperform | RBC Capital Markets |
Werbung
Werbung